IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,504,790 | -7.3% | 121,452 | -22.5% | 0.19% | -31.5% |
| Q3 2022 | $1,623,000 | +28.8% | 156,626 | +43.4% | 0.28% | -9.1% |
| Q2 2022 | $1,260,000 | -8.3% | 109,240 | 0.0% | 0.31% | +10.0% |
| Q1 2022 | $1,374,000 | -46.1% | 109,240 | -50.0% | 0.28% | +6.9% |
| Q4 2021 | $2,548,000 | +78.6% | 218,480 | +100.0% | 0.26% | -16.1% |
| Q3 2021 | $1,427,000 | +54.8% | 109,240 | +52.5% | 0.31% | +87.3% |
| Q2 2021 | $922,000 | +15.4% | 71,615 | +0.2% | 0.17% | +13.7% |
| Q1 2021 | $799,000 | -1.8% | 71,494 | 0.0% | 0.15% | -16.1% |
| Q4 2020 | $814,000 | +66.5% | 71,494 | +31.5% | 0.17% | +34.9% |
| Q3 2020 | $489,000 | -12.8% | 54,350 | 0.0% | 0.13% | -9.2% |
| Q2 2020 | $561,000 | +2.4% | 54,350 | 0.0% | 0.14% | -15.5% |
| Q1 2020 | $548,000 | -6.0% | 54,350 | +24.0% | 0.17% | +54.1% |
| Q4 2019 | $583,000 | -52.9% | 43,816 | -43.4% | 0.11% | -53.8% |
| Q1 2015 | $1,238,000 | – | 77,359 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |